https://www.pharmacytimes.com/watch 0.50 https://www.pharmacytimes.com/insights/innovations-in-the-treatment-of-chronic-lymphocytic-leukemia 2021-06-30 0.50 https://www.pharmacytimes.com/insights/on-the-shelf-video-series 2022-04-04 0.50 https://www.pharmacytimes.com/insights/future-directions-in-treatment-of-chronic-lymphocytic-leukemia-cll-with-btk-inhibitors 2022-02-21 0.50 https://www.pharmacytimes.com/insights/navigating-rsv-how-pharmacists-can-lead-the-charge-in-vaccination-for-older-adults 2024-10-04 0.50 https://www.pharmacytimes.com/insights/clinical-adoption-and-impact-of-subcutaneous-immune-checkpoint-inhibitors-in-oncology-practice 2025-10-15 0.50 https://www.pharmacytimes.com/insights/pharmacist-appreciation 2022-12-19 0.50 https://www.pharmacytimes.com/insights/utilizing-clinical-pathways-in-ovarian-cancer 2023-02-09 0.50 https://www.pharmacytimes.com/insights/optimizing-rsv-vaccination-the-pharmacist-s-role-in-patient-care 2025-05-05 0.50 https://www.pharmacytimes.com/insights/menin-inhibitors-in-aml-pharmacist-insights-on-revumenib-and-ziftomenib 2026-06-26 0.50 https://www.pharmacytimes.com/insights/navigating-egfr-mutated-nsclc-clinical-insights-for-pharmacists-on-personalized-care 2025-04-14 0.50 https://www.pharmacytimes.com/insights/second-line-maintenance-therapy-in-ovarian-cancer-parp-inhibitors 2021-09-28 0.50 https://www.pharmacytimes.com/insights/treatment-innovations-in-waldenstrom-macroglobulinemia 2021-12-03 0.50 https://www.pharmacytimes.com/insights/the-use-of-combination-therapies-in-the-frontline-setting-for-cll 2023-02-02 0.50 https://www.pharmacytimes.com/insights/pharmacist-impact-in-cml-advancing-access-and-frontline-treatment-decisions 2025-06-27 0.50 https://www.pharmacytimes.com/insights/the-evolving-role-of-btk-inhibitors-in-the-treatment-of-relapsed-refractory-mantle-cell-lymphoma 2022-06-20 0.50 https://www.pharmacytimes.com/insights/hemophilia-a-management-a-review-of-prophylaxis-options 2022-12-12 0.50 https://www.pharmacytimes.com/insights/optimizing-pneumococcal-prevention-clinical-updates-and-implementation-strategies-for-pharmacy 2025-06-27 0.50 https://www.pharmacytimes.com/insights/optimizing-patient-outcomes-with-prescription-discount-programs 2021-07-08 0.50 https://www.pharmacytimes.com/insights/treatment-innovations-in-relapsed-refractory-marginal-zone-lymphoma 2021-11-22 0.50 https://www.pharmacytimes.com/insights/role-of-the-clinical-pharmacist-in-multiple-myeloma-management 2025-06-09 0.50 https://www.pharmacytimes.com/insights/the-impact-of-new-data-released-at-ash-2022-on-the-treatment-landscape-of-cml-and-ph-all 2022-12-14 0.50 https://www.pharmacytimes.com/insights/understanding-gastroesophageal-adenocarcinoma-what-pharmacists-should-know 2026-03-11 0.50 https://www.pharmacytimes.com/insights/targeted-therapy-treatment-innovations-in-aml 2021-08-26 0.50 https://www.pharmacytimes.com/insights/biosimilars-in-specialty-pharmacy-navigating-approvals-enhancing-care-and-optimizing-integration 2024-08-15 0.50 https://www.pharmacytimes.com/insights/the-newest-tool-in-the-bag-a-pharmacist-s-guide-to-third-line-cgvhd-therapy 2026-07-01 0.50 https://www.pharmacytimes.com/insights/ohcm-insights-best-practices-for-clinical-pharmacists-in-targeted-cmi-therapy 2026-02-13 0.50 https://www.pharmacytimes.com/insights/advancing-treatment-of-egfr-positive-metastatic-non-small-cell-lung-cancer 2024-06-21 0.50 https://www.pharmacytimes.com/insights/the-evolving-treatment-landscape-in-cll-updates-from-ash-2021 2022-01-21 0.50 https://www.pharmacytimes.com/insights/breast-cancer-insights-updates-from-the-2023-asco-annual-meeting 2023-09-08 0.50 https://www.pharmacytimes.com/insights/pneumococcal-insights-data-guidance-and-real-world-pharmacy-practice 2026-01-22 0.50 https://www.pharmacytimes.com/insights/optimizing-implementation-of-emerging-preferred-oncology-therapies-targeting-egfr-in-nsclc 2025-12-17 0.50 https://www.pharmacytimes.com/insights/empowering-pharmacists-enhancing-rsv-knowledge-and-vaccine-advocacy 2024-05-23 0.50 https://www.pharmacytimes.com/insights/advancing-shingles-prevention-best-practices-for-effective-vaccination-and-patient-engagement 2025-08-29 0.50 https://www.pharmacytimes.com/insights/optimizing-cll-care-navigating-treatment-modifications-and-managing-adverse-events 2024-09-12 0.50 https://www.pharmacytimes.com/insights/esmo-2025-highlights-in-breast-cancer-treatment-with-cdk4-6-inhibitors 2025-12-04 0.50 https://www.pharmacytimes.com/insights/advancements-and-updates-in-the-treatment-options-for-cll 2021-04-15 0.50 https://www.pharmacytimes.com/insights/advancements-and-updates-in-therapies-for-cll 2021-04-15 0.50 https://www.pharmacytimes.com/insights/advancements-in-the-treatment-and-management-of-her2-positive-early-breast-cancer 2021-04-15 0.50 https://www.pharmacytimes.com/insights/anticoagulant-and-antiplatelet-therapies 2021-04-15 0.50 https://www.pharmacytimes.com/insights/biosimilars-pharmacy-interchangeability 2021-04-15 0.50 https://www.pharmacytimes.com/insights/cardiovascular-benefits-of-glp1-agonists 2021-04-15 0.50 https://www.pharmacytimes.com/insights/chemotherapy-induced-nausea-and-vomiting 2021-04-15 0.50 https://www.pharmacytimes.com/insights/combination-therapies-for-treatment-of-type-2-diabetes 2021-04-15 0.50 https://www.pharmacytimes.com/insights/concentrated-insulin-therapy-in-advanced-type-2-diabetes 2021-04-15 0.50 https://www.pharmacytimes.com/insights/economic-burden-of-absssi 2021-04-15 0.50 https://www.pharmacytimes.com/insights/implications-of-potential-heparin-shortage 2021-04-15 0.50 https://www.pharmacytimes.com/insights/management-of-chemotherapy-induced-nausea-and-vomiting 2021-04-15 0.50 https://www.pharmacytimes.com/insights/management-of-melanoma 2021-04-15 0.50 https://www.pharmacytimes.com/insights/opportunities-to-improve-pharmacy-workflow-in-the-preparation-of-levothyroxine 2021-04-15 0.50 https://www.pharmacytimes.com/insights/patient-selection-and-safety-with-tnf-inhibitors 2021-04-15 0.50 https://www.pharmacytimes.com/insights/pharmacists-knowledge-in-home-drug-testing 2021-04-15 0.50 https://www.pharmacytimes.com/insights/proper-dosing-of-anticoagulants-in-cadpad 2021-04-15 0.50 https://www.pharmacytimes.com/insights/sequencing-of-therapy-for-rheumatoid-arthritis 2021-04-15 0.50 https://www.pharmacytimes.com/insights/stroke-prevention-in-atrial-fibrillation 2021-04-15 0.50 https://www.pharmacytimes.com/insights/travel-health 2021-04-15 0.50 https://www.pharmacytimes.com/insights/understanding-axial-spondyloarthritis 2021-04-15 0.50 https://www.pharmacytimes.com/insights/value-based-payment-models 2021-04-15 0.50 https://www.pharmacytimes.com/insights/weight-loss-interventions-for-obesity 2022-04-04 0.50 https://www.pharmacytimes.com/medcast/test-1 2024-10-16 0.50 https://www.pharmacytimes.com/medcast/pharmacists-at-the-forefront-advancing-care-for-patients-with-ros1-nsclc 2025-10-15 0.50 https://www.pharmacytimes.com/medcast/protecting-against-shingles-discussing-with-patients-why-vaccination-matters 2024-10-15 0.50 https://www.pharmacytimes.com/medcast/advancing-pharmacist-engagement-in-biliary-tract-cancer-disease-state-and-treatment 2025-07-10 0.50 https://www.pharmacytimes.com/medcast-series/treating-worsening-congestion-with-subcutaneous-furosemide 2026-07-21 0.50 https://www.pharmacytimes.com/medcast-series/pharmacists-guide-to-solriamfetol-for-excessive-daytime-sleepiness-in-narcolepsy-and-osa 2026-07-22 0.50 https://www.pharmacytimes.com/medcast-series/at-home-testing-as-a-catalyst-for-better-pharmacy-care-a-pharmacist-s-guide-to-supporting 2026-07-30 0.50 https://www.pharmacytimes.com/peer-exchange/optimizing-ldl-c-lowering-therapy-adherence-guidelines-and-novel-treatments 2026-04-30 0.50 https://www.pharmacytimes.com/peer-exchange/advances-in-microbiome-based-therapies-for-recurrent-c-difficile-infection 2023-05-05 0.50 https://www.pharmacytimes.com/peer-exchange/strengthening-adult-immunity-the-importance-of-pneumococcal-vaccination 2025-06-23 0.50 https://www.pharmacytimes.com/peer-exchange/potential-role-of-jak-inhibitors-in-atopic-dermatitis-treatment 2021-10-06 0.50 https://www.pharmacytimes.com/peer-exchange/the-pharmacist-s-role-in-rsv-prevention-and-education 2024-04-30 0.50 https://www.pharmacytimes.com/peer-exchange/migraine-treatment-landscape-and-the-role-of-the-pharmacist 2022-04-04 0.50 https://www.pharmacytimes.com/peer-exchange/advancing-care-in-metastatic-breast-cancer-insights-data-practical-strategies 2025-10-22 0.50 https://www.pharmacytimes.com/peer-exchange/enhancing-biomarker-driven-care-and-disability-detection-in-multiple-sclerosis-clinical-and-pharmacy-practice-strategies 2026-01-27 0.50 https://www.pharmacytimes.com/peer-exchange/the-vital-role-of-annual-flu-vaccines-in-protecting-public-health 2023-07-05 0.50 https://www.pharmacytimes.com/peer-exchange/the-expanse-of-supportive-care-in-myelodysplastic-syndromes-mds 2022-12-12 0.50 https://www.pharmacytimes.com/peer-exchange/key-updates-in-cdk4-6-inhibitors-for-hr-her2-metastatic-breast-cancer 2023-09-18 0.50 https://www.pharmacytimes.com/peer-exchange/tardive-dyskinesia-uncovered-early-detection-and-collaborative-management-approaches 2026-06-29 0.50 https://www.pharmacytimes.com/peer-exchange/tardive-dyskinesia-in-focus-practical-strategies-for-early-recognition-and-coordinated-care 2025-12-18 0.50 https://www.pharmacytimes.com/peer-exchange/beyond-hot-flashes-a-pharmacist-s-guide-to-the-neuroscience-and-new-therapies-of-menopause 2026-06-03 0.50 https://www.pharmacytimes.com/peer-exchange/recent-approvals-in-vaccination-against-sars-cov-2-and-the-omicron-subvariants 2022-10-24 0.50 https://www.pharmacytimes.com/peer-exchange/key-updates-in-the-management-of-patients-with-hyperlipidemia 2024-12-05 0.50 https://www.pharmacytimes.com/peer-exchange/optimizing-tardive-dyskinesia-care-strategies-to-advance-treatment-approaches 2025-03-03 0.50 https://www.pharmacytimes.com/peer-exchange/advancing-tardive-dyskinesia-care-from-risk-identification-through-treatment-selection-and-care 2025-06-23 0.50 https://www.pharmacytimes.com/peer-exchange/adoption-of-oncology-biosimilars-into-clinical-practice 2021-04-02 0.50 https://www.pharmacytimes.com/peer-exchange/enhancing-the-pharmacist-s-role-in-myelofibrosis-care-addressing-treatment-challenges 2025-06-23 0.50 https://www.pharmacytimes.com/peer-exchange/assessing-the-significance-of-rsv-vaccines-in-adult-populations 2023-06-30 0.50 https://www.pharmacytimes.com/peer-exchange/evolving-treatment-landscape-for-relapsed-refractory-multiple-myeloma 2022-12-14 0.50 https://www.pharmacytimes.com/peer-exchange/beyond-the-pd-1-class-effect-in-advanced-endometrial-cancer-empowering-pharmacists-to-navigate 2026-04-09 0.50 https://www.pharmacytimes.com/peer-exchange/the-critical-importance-of-pneumococcal-vaccines-in-protecting-adult-populations 2023-07-05 0.50 https://www.pharmacytimes.com/peer-exchange/closing-the-gaps-in-rsv-immunization-a-pharmacist-s-guide-to-implementation-and-optimization 2026-02-26 0.50 https://www.pharmacytimes.com/peer-exchange/the-relationship-between-the-gut-microbiome-and-management-of-c-difficile 2022-04-05 0.50 https://www.pharmacytimes.com/peer-exchange/advancements-and-considerations-in-the-treatment-of-heart-failure 2022-04-04 0.50 https://www.pharmacytimes.com/peer-exchange/cgvhd-management-in-focus-emerging-therapies-guidelines-and-pharmacist-led-strategies 2025-06-23 0.50 https://www.pharmacytimes.com/peer-exchange/from-tertiary-centers-to-community-settings-effective-implementation-of-bispecific-antibody-therapies 2024-11-19 0.50 https://www.pharmacytimes.com/peer-exchange/precision-perspectives-navigating-advancements-in-hr-her2-negative-breast-cancer-care 2024-05-14 0.50 https://www.pharmacytimes.com/peer-exchange/best-practices-in-multidisciplinary-care-in-aml 2025-06-23 0.50 https://www.pharmacytimes.com/peer-exchange/advancing-patient-care-with-antibody-drug-conjugate-therapies-in-her2-negative-and-her2-low 2024-12-23 0.50 https://www.pharmacytimes.com/peer-exchange/important-updates-in-cdk4-6-usage-in-patients-with-breast-cancer 2025-09-22 0.50 https://www.pharmacytimes.com/peer-exchange/pharmacists-role-in-women-s-health-individualized-strategies-for-menopause-management 2024-12-23 0.50 https://www.pharmacytimes.com/peer-exchange/enhancing-access-to-lipid-lowering-therapies-and-optimizing-cholesterol-management 2024-04-25 0.50 https://www.pharmacytimes.com/peer-exchange/emerging-treatment-options-for-recurrent-c-difficile-infection 2022-07-20 0.50 https://www.pharmacytimes.com/peer-exchange/a-pharmacist-s-perspective-reviewing-the-latest-long-term-data-on-cdk4-6-inhibitors-for-breast 2026-03-17 0.50 https://www.pharmacytimes.com/peer-exchange/clinical-pearls-for-optimizing-rsv-vaccination-in-adult-patients 2025-07-11 0.50 https://www.pharmacytimes.com/peer-exchange/key-updates-in-hemophilia-management-a-discussion-for-pharmacists 2025-12-17 0.50 https://www.pharmacytimes.com/peer-exchange/assessing-treatment-options-for-patients-with-anemia-secondary-to-myelofibrosis 2025-12-16 0.50 https://www.pharmacytimes.com/peer-exchange/the-opioid-crisis-a-multidisciplinary-perspective-on-effective-management 2021-04-20 0.50 https://www.pharmacytimes.com/peer-exchange/advancements-in-the-management-of-immune-thrombocytopenia 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/advances-mbc 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/an-overview-of-the-hemophilia-treatment-paradigm 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/anticoagulant-management 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/benefitsofglp1agonistsfortype2diabetes 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/cardio-diabetes 2022-04-04 0.50 https://www.pharmacytimes.com/peer-exchange/cll-oral-oncolytics 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/current-and-future-considerations-in-the-treatment-of-relapsedrefractory-multiple-myeloma 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/diagnosis-and-treatment-of-irritable-bowel-syndrome 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/expert-perspectives-on-advances-in-the-management-of-c-difficile 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/flu-immunization 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/heart-failure 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/hepatic-encephalopathy-management 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/improving-collaborative-care-in-diabetes 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/management-of-chemotherapy-induced-nausea-and-vomiting 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/management-of-opioid-induced-chronic-constipation 2022-06-02 0.50 https://www.pharmacytimes.com/peer-exchange/management-optimization-in-atopic-dermatitis 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/practice-of-specialty-pharmacy 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/reducing-cardiovascular-disease-risk-through-optimal-lipid-management 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/schizophrenia-relapse-prevention 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/serious-mental-illness 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/sglt2-diabetes 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/the-progression-of-immunization- 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/the-role-for-biosimilars-in-oncology 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/the-role-of-parp-inhibitors--in-ovarian-cancer 2021-04-15 0.50 https://www.pharmacytimes.com/peer-exchange/understanding-drug-shortages 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/responsible-opioid-stewardship-across-populations-optimizing-alternatives-and-mitigating-risks 2024-01-31 0.50 https://www.pharmacytimes.com/practice-pearls/advancing-bcma-targeted-therapies-in-relapsed-refractory-multiple-myeloma-clinical-integration 2026-07-08 0.50 https://www.pharmacytimes.com/practice-pearls/the-role-of-parp-inhibitors-in-the-management-of-ovarian-cancer 2021-12-17 0.50 https://www.pharmacytimes.com/practice-pearls/practice-pearls-clinical-trial-updates-from-esmo-2025-covering-antibody-drug-conjugates-in 2025-11-25 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-in-treatment-and-management-of-indolent-relapse-multiple-myeloma 2023-06-15 0.50 https://www.pharmacytimes.com/practice-pearls/navigating-the-new-era-of-primary-biliary-cholangitis-treatments 2024-12-18 0.50 https://www.pharmacytimes.com/practice-pearls/the-emerging-role-of-bispecific-antibodies-in-diffuse-large-b-cell-lymphoma-management 2025-06-23 0.50 https://www.pharmacytimes.com/practice-pearls/targeted-treatment-of-hr-her2-breast-cancer 2022-06-23 0.50 https://www.pharmacytimes.com/practice-pearls/operationalizing-treatment-with-bispecifics-for-multiple-myeloma 2024-05-08 0.50 https://www.pharmacytimes.com/practice-pearls/managing-multiple-myeloma-how-pharmacists-drive-success-in-optimizing-patient-care 2025-06-23 0.50 https://www.pharmacytimes.com/practice-pearls/real-world-perspectives-on-bispecific-antibody-implementation-in-multiple-myeloma-lessons-from 2026-06-25 0.50 https://www.pharmacytimes.com/practice-pearls/effective-implementation-of-quality-care-programs-for-patients-with-myeloproliferative-neoplasms 2022-04-20 0.50 https://www.pharmacytimes.com/practice-pearls/advancing-care-in-colorectal-cancer-navigating-treatment-after-progression 2025-07-30 0.50 https://www.pharmacytimes.com/practice-pearls/treatment-landscape-recent-clinical-data-role-of-specialty-pharmacists-hemophilia-a 2023-10-18 0.50 https://www.pharmacytimes.com/practice-pearls/optimizing-patient-care-in-hepatic-encephalopathy 2024-04-16 0.50 https://www.pharmacytimes.com/practice-pearls/understanding-the-treatment-landscape-for-cll 2022-01-24 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-health-system-pharmacy-during-covid-19 2022-04-05 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-prophylactic-therapy-in-hemophilia-a 2021-06-23 0.50 https://www.pharmacytimes.com/practice-pearls/practice-pearl-2-review-of-studies-for-prevention-of-vte 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-the-management-of-acute-myeloid-leukemia 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-the-management-of-hepatitis-c 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-the-management-of-neuroendocrine-tumors 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-the-management-of-thromboembolism 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-the-treatment-of-hemophilia 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-the-use-of-direct-oral-anticoagulants-in-obesity 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/best-practices-for-transitioning-from-intravenous-to-subcutaneous-dosing 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/dispensingmultiplemyelomameds 2021-04-15 0.50 https://www.pharmacytimes.com/practice-pearls/practice-pearl-2-risks-and-benefits-of-the-role-of-doacs-for-prevention-of-vte 2021-04-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/women-s-health-and-the-role-of-the-pharmacist 2021-11-02 0.50 https://www.pharmacytimes.com/webinars-webcasts/breast-cancer-treatment-updates 2022-05-19 0.50 https://www.pharmacytimes.com/webinars-webcasts/pharmacy-times-webcast-women-pharmacist-day 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/2020-next-generation-pharmacist-awards-ceremony 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/parp-inhibitors-in-the-treatment-of-ovarian-cancer 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/webcast-cancer-care-updates-in-the-era-of-covid-19 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/updates-in-the-treatment-of-dry-eye 2021-07-22 0.50 https://www.pharmacytimes.com/webinars-webcasts/webcast-ketamine-therapy-and-the-pharmacist 2021-10-21 0.50 https://www.pharmacytimes.com/webinars-webcasts/best-practices-for-management-of-acute-myeloid-leukemia 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/understanding-the-role-of-the-covid-19-pandemic-in-increased-substance-use-disorder 2022-10-27 0.50 https://www.pharmacytimes.com/webinars-webcasts/immunization-practices-during-the-covid-19-pandemic 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/oral-oncolytics-in-the-covid-19-era 2022-02-17 0.50 https://www.pharmacytimes.com/webinars-webcasts/community-pharmacy-center-of-immunization-services 2021-07-27 0.50 https://www.pharmacytimes.com/webinars-webcasts/covid-19-expectations-on-the-roll-out-of-booster-shots 2021-12-23 0.50 https://www.pharmacytimes.com/webinars-webcasts/impact-of-long-acting-hiv-prevention-drugs 2022-03-21 0.50 https://www.pharmacytimes.com/webinars-webcasts/the-impact-of-substance-misuse-during-the-covid-19-pandemic 2022-04-04 0.50 https://www.pharmacytimes.com/webinars-webcasts/managing-oral-oncolytics-through-covid-19 2021-07-15 0.50 https://www.pharmacytimes.com/webinars-webcasts/webcast-the-future-of-psychedelic-medicine-the-role-of-the-pharmacy 2021-12-17 0.50 https://www.pharmacytimes.com/webinars-webcasts/clinical-insights-childhood-vaccine-schedule-changes 2026-05-20 0.50 https://www.pharmacytimes.com/webinars-webcasts/helping-manage-the-cost-of-cancer-with-a-patient-lens-opportunities-for-pharmacists 2022-06-20 0.50 https://www.pharmacytimes.com/webinars-webcasts/managing-allergic-rhinitis-in-special-populations-a-holistic-approach 2022-05-31 0.50 https://www.pharmacytimes.com/webinars-webcasts/webcast-best-practices-in-oncology-pharmacy-specialty-pharmacy-oversight 2021-09-02 0.50 https://www.pharmacytimes.com/webinars-webcasts/pharmacist-provided-immunizations-and-updates-on-covid-19-vaccines-and-recommendations 2022-07-14 0.50 https://www.pharmacytimes.com/webinars-webcasts/use-of-parp-inhibitors-in-breast-cancer-implications-for-pharmacy-practice 2022-08-30 0.50 https://www.pharmacytimes.com/webinars-webcasts/webcast-the-impact-of-the-federal-retail-pharmacy-program-on-covid-19-vaccinations-and-pharmacis 2022-04-04 0.50 https://www.pharmacytimes.com/webinars-webcasts/the-value-of-the-pharmacist-in-treating-covid-19 2021-07-15 0.50 https://www.pharmacytimes.com/podcasts/the-tell-tale-heart-the-pharmacist-s-cardiovascular-digest 2026-07-20 0.50 https://www.pharmacytimes.com/podcasts/pharmacy-focus 2026-07-20 0.50 https://www.pharmacytimes.com/podcasts/oncology-edition 2026-07-20 0.50 https://www.pharmacytimes.com/the-weekly-dose 2026-07-28 0.50 https://www.pharmacytimes.com/perfect-consult 2026-07-20 0.50 https://www.pharmacytimes.com/interviews 2026-07-20 0.50